Showing 1 - 7 results of 7 for search 'Marie Lazarova', query time: 0.03s Refine Results
  1. 1
    Heart failure disease management program, its contribution to established pharmacotherapy and long-term prognosis in real clinical practice - retrospective data analysis

    Heart failure disease management program, its contribution to established pharmacotherapy and long-term prognosis in real clinical practice - retrospective data analysis by Marie Lazarova, Dusan Lazar, Filip Malek, Jan Vaclavik, Milos Taborsky, Andrew Ignaszewski

    Published 2019-12-01
    Get full text
    Article
  2. 2
    Secretoneurin as a Novel Biomarker of Cardiovascular Episodes: Are We There Yet? A Narrative Review

    Secretoneurin as a Novel Biomarker of Cardiovascular Episodes: Are We There Yet? A Narrative Review by Jiří Plášek, Marie Lazárová, Jozef Dodulík, Patrik Šulc, David Stejskal, Zdeněk Švagera, František Všianský, Jan Václavík

    Published 2022-12-01
    Get full text
    Article
  3. 3
    Beta-blockers utilization in heart failure patients: Sub-analysis of a nation-wide population-based study in the Czech Republic

    Beta-blockers utilization in heart failure patients: Sub-analysis of a nation-wide population-based study in the Czech Republic by Milos Taborsky, Renata Aiglova, Marie Lazarova, Ludek Pavlu, Josef Danek, Jan Precek, Alexander Schee, Vit Gloger, Marek Vicha, Tomas Skala

    Published 2021-11-01
    Get full text
    Article
  4. 4
    Angiotensin-converting enzyme inhibitors, angiotensin-II-receptor antagonists and angiotensin-receptor blocker/neprilysin inhibitor utilization in heart failure patients: Sub-analysis of a nation-wide population-based study in the Czech Republic

    Angiotensin-converting enzyme inhibitors, angiotensin-II-receptor antagonists and angiotensin-receptor blocker/neprilysin inhibitor utilization in heart failure patients: Sub-analy... by Renata Aiglova, Milos Taborsky, Marie Lazarova, Ludek Pavlu, Josef Danek, Jan Precek, Alexander Schee, Vit Gloger, Vlastimil Cernicek, Marek Vicha, Tomas Skala

    Published 2022-09-01
    Get full text
    Article
  5. 5
    Corrigendum: Secretoneurin levels are higher in dilated cardiomyopathy than in ischaemic cardiomyopathy: preliminary results

    Corrigendum: Secretoneurin levels are higher in dilated cardiomyopathy than in ischaemic cardiomyopathy: preliminary results by Jiří Plášek, Jiří Plášek, Jozef Dodulík, Marie Lazárová, David Stejskal, David Stejskal, Zdeněk Švagera, Zdeněk Švagera, Nela Chobolová, Patrik Šulc, Lukáš Evin, Lukáš Evin, Dana Purová, Jan Václavík, Jan Václavík

    Published 2024-04-01
    Get full text
    Article
  6. 6
    Trends in the treatment and survival of heart failure patients: a nationwide population‐based study in the Czech Republic

    Trends in the treatment and survival of heart failure patients: a nationwide population‐based study in the Czech Republic by Milos Táborský, Tomas Skála, Marie Lazárová, Renata Aiglová, Jindrich Špinar, Lenka Špinarová, Jiri Vítovec, Josef Kautzner, Vojtech Melenovský, Filip Málek, Ladislav Dušek, Jiri Jarkovský, Klara Benešová, Marek Vícha, Ales Linhart

    Published 2021-10-01
    Get full text
    Article
  7. 7
    Secretoneurin levels are higher in dilated cardiomyopathy than in ischaemic cardiomyopathy: preliminary results

    Secretoneurin levels are higher in dilated cardiomyopathy than in ischaemic cardiomyopathy: preliminary results by Jiří Plášek, Jiří Plášek, Jozef Dodulík, Marie Lazárová, David Stejskal, David Stejskal, Zdeněk Švagera, Zdeněk Švagera, Nela Chobolová, Patrik Šulc, Lukáš Evin, Lukáš Evin, Dana Purová, Jan Václavík, Jan Václavík

    Published 2024-01-01
    Get full text
    Article

Search Tools: